Navigation Links
Flo-Mist™ Continuous Medication Nebulizer (CMN)

ProductsFlo-Mist™ Continuous Medication Nebulizer (CMN)
Company DHD Healthcare
Item Flo-Mist™ Continuous Medication Nebulizer (CMN)
Features 
  • Auxiliary port --Allows the clinician to add an auxiliary gas flow without recalculating the medication.
  • Rescue Valve --Located in the non-rebreather circuit, a fail-safe one-way valve in the valved Y piece that allows the patient to entrain ambient air should their inspiratory demand exceed the system.
  • Connects directly to flowmeter --Once connected to the flowmeter, Flo-Mist is fully secured and easy to access for refilling.
  • Up to 8 hours of continuous therapy --Flo-Mist delivers medications as well as humidification for any prescribed length of time up to 8 hours.
  • Dosing chart included --Convenient dosing chart included in each package for quick reference.
  • Aerosol and non-rebreather kits --A fast and convenient way to administer therapy in emergency care settings.
  • Standard 22mm aerosol port --Use your existing tubing or purchase Flo-Mist as a kit.
  • Colorful graphics and gradients --Easy to read gradient lines calibrated at 5ml, ensuring precise medication delivery.
Description For delivery of medication as well as humidification, try Flo-Mist™.

Flo-Mist™, is a refillable, closed dilution, high volume, continuous medication nebulizer (CMN), engineered to deliver deep inhalation therapy to patients. Its 200 ml reservoir and jet flow design allow for up to 8 hours of nebulized medication delivery at 25 ml/hr. Particles are delivered within the 3 to 5 micron range. Flo-Mist™ is the product of choice for many different applications.

Flo-Mist's smart design allows clinicians to add an auxiliary flow of air, Oxygen or Heliox through the side port, without the hassle of recalculating the medication dosage.

The versatile Flo-Mist™ is available as a single nebulizer or in aerosol and non-rebreathing mask kits, where everything required for an acute treatment is packaged in one convenient kit.

For patients requiring higher concentrations (> 50%) of oxygen, consider Flo-Mist's non-rebreathing mask kit. Designed to allow Oxygen and Heliox delivery to be controlled, it can safely provide patients with the gas concentrations they need. This kit, complete with built-in rescue valve and reservoir bag, allows the patient to entrain room air should the patient's inspiratory demand exceed the system.

Shipped 10 kits per case.

Not licensed for sale in Canada.
Info 

Related medicine products :

1. Flo-Mist™ Continuous Medication Nebulizer (CMN) - Adult Kits
2. Flo-Mist™ Continuous Medication Nebulizer (CMN) - Pediatric Kits
3. CGMS System Gold Continuous Glucose Monitoring
4. Continuous Wave II Arthroscopy Pump
5. DNA Engine Opticon Continuous Fluorescence Detection System
6. DNA Engine Opticon 2 Continuous Fluorescence Detection System
7. USA Elite System™ Rotating Continuous Flow Resectoscopes
8. Continuous Flow Cystoscopes
9. CAVR (Continuous Arteriovenous Rewarming)
10. OMNI~MAX Heliox Rescue Continuous Nebulizer
11. DexCom™ STS™ Continuous Glucose Monitoring System
With its wide orifice tip, the Finntip Wide is designed especially for pipetting fragile cell suspensions and macromolecules like genomic DNA. This tip eliminates the mechanical shearing that causes
200 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less.
Finntips have been designed to optimize the accuracy and precision of Finnpipettes. The quality of our tip products is widely recognized by customers throughout the world. The Finntip range has been
MBP's extra long 200 L pipet tip will reach the bottom of large tubes and vials, preventing your pipettor from contacting the sample container.
Medicine Products:
(Date:10/7/2008)...ve effect in post-HAART era , , TUESDAY,...ting research finds little evidence that circumcis...virus, but the issue is still far from settled. ,...ge of powerful AIDS drugs showed that circumcision... has launched the most definitive type of research...
(Date:10/7/2008)...ewswire/ -- Join Mii amo, a destination spa,at Enc...ona,s red rock,country honoring the winter solstic...raditional Native American ceremonies facilitated ...d special guest, Elder George,Goodstriker., Goods...e Blood Reserve,in Standoff, Alberta, Canada,s lar...
(Date:10/7/2008)... Man Wanted to Know But Was Afraid to Ask!, LOS A...on babies born,in the U.S. each year but there,s n... DAD is a revealing, entertaining and inspirationa...s for dads-to-be from fathers who,have recently go...includes,a wealth of advice from several experts i...
(Date:10/7/2008)...storm Corporation ( www.wyndstorm.com ) (OTCBB:WYN...nounced a key win with Muve, Inc. ( www.muveinc.co...am design to promote Muve,s activity-based corpora...ll ultimately help Muve,s corporate clients foster...interactive messaging, rewards programs, tips, cha...
Breaking Medicine News(10 mins):Health News:Role of Circumcision in Reducing HIV Risk Still Unclear 2Health News:Mii amo Honors Winter Solstice With Traditional Native American Celebration December 18-21 2Health News:BEING DAD DVD Offers a Sneak Peek at Pregnancy From a Guy's Point of View 2Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 2Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 3
...d that consuming just two cups of green tea could ...ts in Texas in collaboration with their counterpar...eatured in the online edition of the Journal of Al...dy revealed that a major polyphenol called epigall...
...al cancer and deaths from the disease are alarming..., 20,000 cases //of colorectal cancer have been re... are expected every year. In the US, it is 140,000...ers for Disease Control and Prevention. Cancer Res...
...f the eyes can diagnose cerebral malaria in childr...a severe complication where the Plasmodium falcipa... the tissues of the brain, is difficult to detect ...s and have a number of other illnesses. The morta...
...nistration of U.S has chalked out a seemingly fool...f safety //and efficiency of medical gadgets that ...patients requiring them for various medical reason...e in the market today in the U.S accounts for a wh...
Other Medicine News:Health News:The Anti-HIV Properties Of Green Tea Uncovered 2Health News:Novel Plans Of FDA To Monitor Safety Of Medical Devices 2
(Date:10/7/2008)...n once-daily significantly,improved the symptoms o...ewswire-FirstCall/ -- Shire plc (LSE: SHP,Nasdaq:...mpany, today,announced that a study published in t...hiatry found once-daily VYVANSE significantly impr...D) symptoms in adults within,the first week of tre...
(Date:10/7/2008)...ligen Therapeutics Inc.,today announced that in vi...dates were presented at the XXII International Com...ighlighted the candidates, efficacy in,several ani...se highlighted presentations, as well as several i...l the deep expertise and expanding,knowledge base ...
(Date:10/7/2008)...trolled Phase II Study Shows Statisticall...N VIEW, California, October 7 /- BN,I...se II data from the,therapeutic prostate cancer va...d as part of the recently entered partnership with...The results from the Phase II prospective randomiz...
(Date:10/7/2008)...for Use on the GeneXpert(R) ...wswire-FirstCall/ -- Cepheid (Nasdaq:,CPHD) today ...European CE,IVD Mark product under the European Di...e test delivers rapid detection of vanA and/or van...ancomycin-resistant,enterococci (VRE) -- one of th...
Breaking Medicine Technology:Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Best Practice Database 3A Complimentary Excerpt of Designing Effective Brand Teams 3A Structure Governance Performance and Operations 5408 1Best Practice Database 3A Complimentary Excerpt of Designing Effective Brand Teams 3A Structure Governance Performance and Operations 5408 2President Musevenis Visit Protested by HIV AIDS Experts 5405 1President Musevenis Visit Protested by HIV AIDS Experts 5405 2VIDEO from Medialink and EcoQuest 3A New Technology Reduces Exposure to MRSA Staph 5402 1Meredith Martin Addy Named Chair of AIPLAs Amicus Committee 1676 1Meredith Martin Addy Named Chair of AIPLAs Amicus Committee 1676 2
... clinical development program of first-in-class CB...ight reduction and,avoid image as life-style drug ... Intelligence,firm La Merie S.L. reported today th...nist Acomplia (rimonabant) has at least,five compe... more,in earlier phases of R&D. While Acomplia...
...pany Outlines Development Plans - , ,OTTAWA, Canad...LPX), a biopharmaceutical company specializing in ...ty Lipoprotein (HDL), often,called “good cho...ase I/II Clinical Trial of its lead product, CRD5....ipidemia and heart,disease. , ,Results showed, to ...
Other Medicine Technology:Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 2Weight Management is Not Enough for Cannabinoid Type 1 (CB1),Receptor Antagonists to Become a Commercial Success 3Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 2Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 3